Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3174 of 6351
-
Hot pepper patch targets stubborn tailbone pain
Symptom relief Recruiting nowA retrospective study over a period of 6 years to explore analgesic efficacy of 8% Capsaicin patch (QUTENZA®) in coccygodynic patients, as well as neuropathic predictive factors of therapeutic response.
Sponsor: Nantes University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
New skin flap could reduce surgery side effects for head and neck cancer patients
Disease control Recruiting nowThis is a phase 1b, multicenter, non-randomized prospective study involving an innovation phase (IDEAL-1) followed by a prospective development phase (IDEAL-2A) designed to evaluate the safety and feasibility of oral/oropharyngeal reconstruction with the external pudendal free fl…
Sponsor: Institut Claudius Regaud • Aim: Disease control
Last updated Jun 26, 2026 17:27 UTC
-
New drug cocktail aims to fight Hard-to-Treat cancers
Disease control Recruiting nowThis phase I trial tests the safety, side effects, and best dose of ZEN003694 in combination with the usual treatment with capecitabine in treating patients with cancer that has spread from where it first started (primary site) to other places in the body (metastatic) or cannot b…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New MRI scan could spot hidden lung damage in PH patients
Knowledge-focused Recruiting nowThe main goal of this study is to develop a noninvasive signature for pulmonary vascular remodeling in Group 3 PH patients, using hyperpolarized 129Xe magnetic resonance imaging (129Xe MRI). Such a signature may identify Group 3 PH responders to PAH-specific therapies. PAH's uniq…
Phase 2 • Sponsor: Bastiaan Driehuys • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
Can a smartphone app ease the burden of migraines? new study aims to find out.
Symptom relief Recruiting nowThis study is a fully powered, remote randomized control trial to evaluate RELAXaHEAD in people with migraine.
Sponsor: NYU Langone Health • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
New study aims to boost timely colonoscopies and prevent colon cancer in High-Risk patients
Knowledge-focused Recruiting nowThis clinical trial tests a multilevel intervention at the clinic, provider and patient levels, to improve colonoscopy surveillance in patients with high risk colon polyps. Colorectal cancer (CRC) is a common and deadly disease that is largely preventable through the detection an…
Sponsor: Jonsson Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
Could a common diabetes drug help kidneys in sepsis?
Disease control CompletedAcute kidney injury (AKI) is an independent risk factor for death that affects 10-15% of hospitalized patients and more than 50% of patients admitted to the intensive care unit. Sepsis is the most frequent cause of AKI, affecting 48 million people worldwide every year, and accoun…
Phase 2 • Sponsor: Hernando Gomez • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Can pressurized oxygen lift the fog of Post-Stroke depression?
Symptom relief Recruiting nowThe study evaluates the effect of HBOT on depression in patients suffering from persistent symptoms of post stroke depression (PSD) in an double blind sham control study.
Sponsor: Assaf-Harofeh Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
Plant-Powered hope: diet may slow prostate cancer
Disease control CompletedThe purpose of this research is to determine if consuming a whole food plant-based diet for six months impacts outcomes in men with prostate cancer that have a rising prostate-specific antigen (PSA) level. The main questions it aims to answer are: Does a whole-food plant-based i…
Sponsor: Pacific Cancer Care • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New brain imaging agent could improve Alzheimer's detection
Diagnosis Recruiting nowThe purpose of this research study is to determine the safety of a radiotracer 18F-Fluselenamyl using positron emission tomography (PET) imaging.
Sponsor: Washington University School of Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 13:04 UTC
-
Can a school program turn the tide on childhood obesity in mexico?
Prevention Recruiting nowThe aims is to evaluate the effects of an multidimensional intervention on the physical-built and social environment around schools and the nutritional status of the school population, through a randomized community trial, in schools in 3 states of the Mexican Republic, using ant…
Sponsor: Mexican National Institute of Public Health • Aim: Prevention
Last updated Jun 27, 2026 07:51 UTC
-
New pill takes on tough cancers: first human trial begins
Disease control CompletedThe purpose of this study is to test the safety and therapeutic effect of TT125-802 (single agent) in subjects with advanced solid tumors.
Phase 1 • Sponsor: TOLREMO therapeutics AG • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New antibody drug takes aim at Hard-to-Treat cancers
Disease control Recruiting nowThis is a first-in-human Phase 1, single-arm, open-label, multicenter, multiple-dose, dose-escalation study of ABL103 to evaluate the safety, tolerability, MTD (maximum tolerated dose) and/or RP2D (recommended phase 2 dose), pharmacokinetics, immunogenicity, preliminary antitumor…
Phase 1 • Sponsor: ABL Bio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New dye could replace radioactive tracers in vulvar cancer surgery
Diagnosis OngoingThe purpose of this study is to compare two types of imaging for sentinel lymph node (SLN) mapping in people with early-stage vulvar cancer. The researchers will compare indocyanine green near-infrared (ICG-NIR) imaging with lymphoscintigraphy. All participants in this study will…
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 07:56 UTC
-
New proton therapy aims to reduce bowel side effects in gynecologic cancer patients
Symptom relief Recruiting nowThis is a single institution, multi-center, Phase II, single-arm study, using Whole Pelvis (WP) Pencil Beam Scanning Proton Radiation (PBS PRT) in the post-surgical, adjuvant setting for definitive treatment of gynecologic cancers. The purpose of this study is to estimate rate of…
Phase 2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Could friendly bacteria help pouch patients poop less?
Symptom relief Recruiting nowThe aim of this study is to assess the safety and preliminary efficacy of treatment with EXE-346, a live biotherapeutic, which may reduce bowel movement frequency in patients with an ileal pouch-anal anastomosis (IPAA) and lead to a higher quality of life.
Phase 1/2 • Sponsor: Exegi Pharma, LLC • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
Probiotic shows promise in easing antibiotic side effects in kids
Symptom relief CompletedAmoxicillin or Amoxicillin/Clavulanic acid antibiotic therapy has been shown to be associated with disrupting the microbiota population particularly Bifidobacterium, which may have further GI clinical implications. The present randomized clinical trial is aimed to assess if prob…
Sponsor: Liaquat University of Medical & Health Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Brainwave device may ease stress for healthcare workers
Symptom relief CompletedRandomized, controlled study of long-term maintenance Cereset Research after an initial 4-session intervention bolus versus usual care control following an initial 4-session intervention bolus.
Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jun 26, 2026 13:32 UTC
-
Could an asthma drug ease Parkinson's symptoms?
Disease control Recruiting nowParkinson's disease (PD) is the second most common neurodegenerative disorder after Alzheimer's disease (AD). Clinical manifestations of PD can vary, but a formal diagnosis relies on the presence of bradykinesia with rigidity and/or rest tremor according to Movement Disorder Soci…
Phase 2/3 • Sponsor: Mostafa Bahaa • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Glue and omental wrap may cut pancreatic surgery risks
Disease control CompletedFollowing pancreaticoduodenectomy, omental flaps around the pancreatic anastomosis and adhesive glue can lower the risk of pancreatic fistula, post-pancreatectomy bleeding, and delayed gastric emptying. The overall morbidity following pancreaticoduodenectomy can be decreased with…
Phase 4 • Sponsor: Theodor Bilharz Research Institute • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC